These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35865520)

  • 1. ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.
    Tsilika M; Taks E; Dolianitis K; Kotsaki A; Leventogiannis K; Damoulari C; Kostoula M; Paneta M; Adamis G; Papanikolaou I; Stamatelopoulos K; Bolanou A; Katsaros K; Delavinia C; Perdios I; Pandi A; Tsiakos K; Proios N; Kalogianni E; Delis I; Skliros E; Akinosoglou K; Perdikouli A; Poulakou G; Milionis H; Athanassopoulou E; Kalpaki E; Efstratiou L; Perraki V; Papadopoulos A; Netea MG; Giamarellos-Bourboulis EJ
    Front Immunol; 2022; 13():873067. PubMed ID: 35865520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic.
    Moorlag SJCFM; Taks E; Ten Doesschate T; van der Vaart TW; Janssen AB; Müller L; Ostermann P; Dijkstra H; Lemmers H; Simonetti E; Mazur M; Schaal H; Ter Heine R; van de Veerdonk FL; Bleeker-Rovers CP; van Crevel R; Ten Oever J; de Jonge MI; Bonten MJ; van Werkhoven CH; Netea MG
    Clin Infect Dis; 2022 Aug; 75(1):e938-e946. PubMed ID: 35247264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.
    Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM;
    mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial.
    Koekenbier EL; Fohse K; van de Maat JS; Oosterheert JJ; van Nieuwkoop C; Hoogerwerf JJ; Grobusch MP; van den Bosch MAAJ; van de Wijgert JHH; Netea MG; Rosendaal FR; Bonten MJM; Werkhoven CHHV;
    Clin Microbiol Infect; 2023 Jun; 29(6):781-788. PubMed ID: 36736662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
    Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
    Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():980711. PubMed ID: 36875134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
    Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
    Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial.
    Messina NL; Pittet LF; McDonald E; Moore C; Barry S; Bonten M; Byrne A; Campbell J; Croda J; Croda MG; Dalcolmo M; de Almeida E Val FF; de Oliveira RD; Dos Santos G; Douglas MW; Gardiner K; Gwee A; Jardim BA; Kollmann T; Lacerda MV; Lucas M; Lynn DJ; Manning L; Marshall H; O'Connell A; Perrett KP; Post JJ; Prat-Aymerich C; Rocha JL; Rodriguez-Baño J; Wadia U; Warris A; Davidson A; Curtis N;
    J Infect; 2024 Oct; 89(4):106245. PubMed ID: 39127450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.
    Blossey AM; Brückner S; May M; Parzmair GP; Sharma H; Shaligram U; Grode L; Kaufmann SHE; Netea MG; Schindler C
    Clin Infect Dis; 2023 Apr; 76(7):1304-1310. PubMed ID: 36358012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses.
    DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD
    Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
    Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
    Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.
    Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected?
    Borges KCM; da Costa AC; de Souza Barbosa LC; Ribeiro KM; Dos Anjos LRB; Kipnis A; Junqueira-Kipnis AP
    Mini Rev Med Chem; 2022; 22(12):1631-1647. PubMed ID: 34983348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2.
    Ramos-Martinez E; Falfán-Valencia R; Pérez-Rubio G; Andrade WA; Rojas-Serrano J; Ambrocio-Ortiz E; Galicia-Álvarez DS; Bárcenas-Montiel I; Velasco-Medina A; Velázquez-Sámano G
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
    Vashishtha VM
    Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.